[
    [
        {
            "time": "2020-03-16",
            "original_text": "Dow Jones Makes Bear Market Correction On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "Bear Market",
                    "Coronavirus",
                    "Stay At Home"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Makes Bear Market Correction On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-02-28",
            "original_text": "Aduro's (ADRO) Earnings & Revenues Miss Estimates in Q4",
            "features": {
                "keywords": [
                    "Aduro",
                    "Earnings",
                    "Revenues",
                    "Miss Estimates"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Aduro's (ADRO) Earnings & Revenues Miss Estimates in Q4",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-03-12",
            "original_text": "Dow Jones Slammed 1,284 Points On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "Slammed",
                    "Coronavirus",
                    "Stay At Home"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Slammed 1,284 Points On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-03-11",
            "original_text": "Dow Jones Slammed 1,151 Points On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "Slammed",
                    "Coronavirus",
                    "Stay At Home"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Slammed 1,151 Points On Coronavirus Fears; Will 'Stay At Home' Stocks Win Big In 2020?",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-04-15",
            "original_text": "Lilly to Participate in New Model Designed to Make Insulins More Affordable for Seniors in Medicare Part D",
            "features": {
                "keywords": [
                    "Lilly",
                    "Insulins",
                    "Affordable",
                    "Medicare"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly to Participate in New Model Designed to Make Insulins More Affordable for Seniors in Medicare Part D",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-02-10",
            "original_text": "Pharma M&A Has Slowed to a Crawl",
            "features": {
                "keywords": [
                    "Pharma",
                    "M&A",
                    "Slowed"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Pharma M&A Has Slowed to a Crawl",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-05",
            "original_text": "Eli Lilly Gets Analyst Praise",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Analyst Praise"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Gets Analyst Praise",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-01-15",
            "original_text": "US govt aims at high insulin prices with plan for $35 copay in Medicare",
            "features": {
                "keywords": [
                    "US govt",
                    "Insulin Prices",
                    "Medicare"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare policy"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US govt aims at high insulin prices with plan for $35 copay in Medicare",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]